カテゴリー： Market Monitor Global, 世界, 医療/バイオ

感染症分子診断の世界市場見通し2023年-2029年

◆英語タイトル：Infectious Diseases Molecular Diagnostics Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8357 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：65 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Infectious Diseases Molecular Diagnostics Market 調査レポートは次の情報を含め、グローバルにおけるの感染症分子診断市場規模と予測を収録しています。・世界の感染症分子診断市場：売上、2018年-2023年、2024年-2029年
・世界の感染症分子診断市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の感染症分子診断市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ポリメラーゼ連鎖反応 PCR」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

感染症分子診断のグローバル主要企業は、Roche、 Qiagen、 Illumina、 Abbott、 Hologic、 BioMerieux、 Danaher (Cepheid)、 Myriad Genetics、 DAAN Gene、 Agilent、 Genomic Health、 BD、 Foundation Medicineなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、感染症分子診断のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の感染症分子診断市場：タイプ別、2018年-2023年、2024年-2029年
世界の感染症分子診断市場：タイプ別市場シェア、2022年
・ポリメラーゼ連鎖反応 PCR、分子ハイブリダイゼーション、バイオチップ、その他

世界の感染症分子診断市場：用途別、2018年-2023年、2024年-2029年
世界の感染症分子診断市場：用途別市場シェア、2022年
・病院、第三者検査機関、その他

世界の感染症分子診断市場：地域・国別、2018年-2023年、2024年-2029年
世界の感染症分子診断市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における感染症分子診断のグローバル売上、2018年-2023年
・主要企業における感染症分子診断のグローバル売上シェア、2022年
・主要企業における感染症分子診断のグローバル販売量、2018年-2023年
・主要企業における感染症分子診断のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Roche、 Qiagen、 Illumina、 Abbott、 Hologic、 BioMerieux、 Danaher (Cepheid)、 Myriad Genetics、 DAAN Gene、 Agilent、 Genomic Health、 BD、 Foundation Medicine

*************************************************************

・調査・分析レポートの概要
感染症分子診断市場の定義
市場セグメント
世界の感染症分子診断市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の感染症分子診断市場規模
世界の感染症分子診断市場規模：2022年 VS 2029年
世界の感染症分子診断市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの感染症分子診断の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の感染症分子診断製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ポリメラーゼ連鎖反応 PCR、分子ハイブリダイゼーション、バイオチップ、その他
感染症分子診断のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、第三者検査機関、その他
感染症分子診断の用途別グローバル売上・予測

・地域別市場分析
地域別感染症分子診断市場規模 2022年と2029年
地域別感染症分子診断売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Roche、 Qiagen、 Illumina、 Abbott、 Hologic、 BioMerieux、 Danaher (Cepheid)、 Myriad Genetics、 DAAN Gene、 Agilent、 Genomic Health、 BD、 Foundation Medicine
...

The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
This report aims to provide a comprehensive presentation of the global market for Infectious Diseases Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Diseases Molecular Diagnostics. This report contains market size and forecasts of Infectious Diseases Molecular Diagnostics in global, including the following market information:
Global Infectious Diseases Molecular Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Infectious Diseases Molecular Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Polymerase Chain Reaction PCR Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Infectious Diseases Molecular Diagnostics include Roche, Qiagen, Illumina, Abbott, Hologic, BioMerieux, Danaher (Cepheid), Myriad Genetics and DAAN Gene, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Infectious Diseases Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Diseases Molecular Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Infectious Diseases Molecular Diagnostics Market Segment Percentages, by Type, 2022 (%)
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Global Infectious Diseases Molecular Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Infectious Diseases Molecular Diagnostics Market Segment Percentages, by Application, 2022 (%)
Hospital
Third-party Testing Agency
Others
Global Infectious Diseases Molecular Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Infectious Diseases Molecular Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infectious Diseases Molecular Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Infectious Diseases Molecular Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine
Outline of Major Chapters:
Chapter 1: Introduces the definition of Infectious Diseases Molecular Diagnostics, market overview.
Chapter 2: Global Infectious Diseases Molecular Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Infectious Diseases Molecular Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Infectious Diseases Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Infectious Diseases Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Infectious Diseases Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Infectious Diseases Molecular Diagnostics Overall Market Size
2.1 Global Infectious Diseases Molecular Diagnostics Market Size: 2022 VS 2029
2.2 Global Infectious Diseases Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Infectious Diseases Molecular Diagnostics Players in Global Market
3.2 Top Global Infectious Diseases Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Infectious Diseases Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Infectious Diseases Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Infectious Diseases Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Infectious Diseases Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Infectious Diseases Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Infectious Diseases Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Infectious Diseases Molecular Diagnostics Market Size Markets, 2022 & 2029
4.1.2 Polymerase Chain Reaction PCR
4.1.3 Molecular Hybridization
4.1.4 Biochip
4.1.5 Others
4.2 By Type – Global Infectious Diseases Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type – Global Infectious Diseases Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type – Global Infectious Diseases Molecular Diagnostics Revenue, 2024-2029
4.2.3 By Type – Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Infectious Diseases Molecular Diagnostics Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Third-party Testing Agency
5.1.4 Others
5.2 By Application – Global Infectious Diseases Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application – Global Infectious Diseases Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application – Global Infectious Diseases Molecular Diagnostics Revenue, 2024-2029
5.2.3 By Application – Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Infectious Diseases Molecular Diagnostics Market Size, 2022 & 2029
6.2 By Region – Global Infectious Diseases Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region – Global Infectious Diseases Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region – Global Infectious Diseases Molecular Diagnostics Revenue, 2024-2029
6.2.3 By Region – Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Infectious Diseases Molecular Diagnostics Revenue, 2018-2029
6.3.2 US Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.3.3 Canada Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.3.4 Mexico Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Infectious Diseases Molecular Diagnostics Revenue, 2018-2029
6.4.2 Germany Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4.3 France Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4.4 U.K. Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4.5 Italy Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4.6 Russia Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4.8 Benelux Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Infectious Diseases Molecular Diagnostics Revenue, 2018-2029
6.5.2 China Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.5.3 Japan Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.5.4 South Korea Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.5.6 India Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Infectious Diseases Molecular Diagnostics Revenue, 2018-2029
6.6.2 Brazil Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.6.3 Argentina Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Infectious Diseases Molecular Diagnostics Revenue, 2018-2029
6.7.2 Turkey Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.7.3 Israel Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.7.5 UAE Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
7 Infectious Diseases Molecular Diagnostics Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Infectious Diseases Molecular Diagnostics Major Product Offerings
7.1.4 Roche Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Qiagen
7.2.1 Qiagen Company Summary
7.2.2 Qiagen Business Overview
7.2.3 Qiagen Infectious Diseases Molecular Diagnostics Major Product Offerings
7.2.4 Qiagen Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Qiagen Key News & Latest Developments
7.3 Illumina
7.3.1 Illumina Company Summary
7.3.2 Illumina Business Overview
7.3.3 Illumina Infectious Diseases Molecular Diagnostics Major Product Offerings
7.3.4 Illumina Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Illumina Key News & Latest Developments
7.4 Abbott
7.4.1 Abbott Company Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Infectious Diseases Molecular Diagnostics Major Product Offerings
7.4.4 Abbott Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Abbott Key News & Latest Developments
7.5 Hologic
7.5.1 Hologic Company Summary
7.5.2 Hologic Business Overview
7.5.3 Hologic Infectious Diseases Molecular Diagnostics Major Product Offerings
7.5.4 Hologic Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Hologic Key News & Latest Developments
7.6 BioMerieux
7.6.1 BioMerieux Company Summary
7.6.2 BioMerieux Business Overview
7.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Major Product Offerings
7.6.4 BioMerieux Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.6.5 BioMerieux Key News & Latest Developments
7.7 Danaher (Cepheid)
7.7.1 Danaher (Cepheid) Company Summary
7.7.2 Danaher (Cepheid) Business Overview
7.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Major Product Offerings
7.7.4 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Danaher (Cepheid) Key News & Latest Developments
7.8 Myriad Genetics
7.8.1 Myriad Genetics Company Summary
7.8.2 Myriad Genetics Business Overview
7.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Major Product Offerings
7.8.4 Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Myriad Genetics Key News & Latest Developments
7.9 DAAN Gene
7.9.1 DAAN Gene Company Summary
7.9.2 DAAN Gene Business Overview
7.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Major Product Offerings
7.9.4 DAAN Gene Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.9.5 DAAN Gene Key News & Latest Developments
7.10 Agilent
7.10.1 Agilent Company Summary
7.10.2 Agilent Business Overview
7.10.3 Agilent Infectious Diseases Molecular Diagnostics Major Product Offerings
7.10.4 Agilent Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Agilent Key News & Latest Developments
7.11 Genomic Health
7.11.1 Genomic Health Company Summary
7.11.2 Genomic Health Business Overview
7.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Major Product Offerings
7.11.4 Genomic Health Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.11.5 Genomic Health Key News & Latest Developments
7.12 BD
7.12.1 BD Company Summary
7.12.2 BD Business Overview
7.12.3 BD Infectious Diseases Molecular Diagnostics Major Product Offerings
7.12.4 BD Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.12.5 BD Key News & Latest Developments
7.13 Foundation Medicine
7.13.1 Foundation Medicine Company Summary
7.13.2 Foundation Medicine Business Overview
7.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Major Product Offerings
7.13.4 Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.13.5 Foundation Medicine Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Infectious Diseases Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Infectious Diseases Molecular Diagnostics Market Drivers in Global Market
Table 3. Infectious Diseases Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Infectious Diseases Molecular Diagnostics in Global Market
Table 5. Top Infectious Diseases Molecular Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Infectious Diseases Molecular Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Infectious Diseases Molecular Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Infectious Diseases Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Infectious Diseases Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Infectious Diseases Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Infectious Diseases Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Infectious Diseases Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Infectious Diseases Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Infectious Diseases Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2024-2029
Table 30. Roche Company Summary
Table 31. Roche Infectious Diseases Molecular Diagnostics Product Offerings
Table 32. Roche Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Qiagen Company Summary
Table 35. Qiagen Infectious Diseases Molecular Diagnostics Product Offerings
Table 36. Qiagen Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Qiagen Key News & Latest Developments
Table 38. Illumina Company Summary
Table 39. Illumina Infectious Diseases Molecular Diagnostics Product Offerings
Table 40. Illumina Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Illumina Key News & Latest Developments
Table 42. Abbott Company Summary
Table 43. Abbott Infectious Diseases Molecular Diagnostics Product Offerings
Table 44. Abbott Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Abbott Key News & Latest Developments
Table 46. Hologic Company Summary
Table 47. Hologic Infectious Diseases Molecular Diagnostics Product Offerings
Table 48. Hologic Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Hologic Key News & Latest Developments
Table 50. BioMerieux Company Summary
Table 51. BioMerieux Infectious Diseases Molecular Diagnostics Product Offerings
Table 52. BioMerieux Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. BioMerieux Key News & Latest Developments
Table 54. Danaher (Cepheid) Company Summary
Table 55. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product Offerings
Table 56. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Danaher (Cepheid) Key News & Latest Developments
Table 58. Myriad Genetics Company Summary
Table 59. Myriad Genetics Infectious Diseases Molecular Diagnostics Product Offerings
Table 60. Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Myriad Genetics Key News & Latest Developments
Table 62. DAAN Gene Company Summary
Table 63. DAAN Gene Infectious Diseases Molecular Diagnostics Product Offerings
Table 64. DAAN Gene Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. DAAN Gene Key News & Latest Developments
Table 66. Agilent Company Summary
Table 67. Agilent Infectious Diseases Molecular Diagnostics Product Offerings
Table 68. Agilent Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Agilent Key News & Latest Developments
Table 70. Genomic Health Company Summary
Table 71. Genomic Health Infectious Diseases Molecular Diagnostics Product Offerings
Table 72. Genomic Health Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 73. Genomic Health Key News & Latest Developments
Table 74. BD Company Summary
Table 75. BD Infectious Diseases Molecular Diagnostics Product Offerings
Table 76. BD Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 77. BD Key News & Latest Developments
Table 78. Foundation Medicine Company Summary
Table 79. Foundation Medicine Infectious Diseases Molecular Diagnostics Product Offerings
Table 80. Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 81. Foundation Medicine Key News & Latest Developments
List of Figures
Figure 1. Infectious Diseases Molecular Diagnostics Segment by Type in 2022
Figure 2. Infectious Diseases Molecular Diagnostics Segment by Application in 2022
Figure 3. Global Infectious Diseases Molecular Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Infectious Diseases Molecular Diagnostics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Infectious Diseases Molecular Diagnostics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Infectious Diseases Molecular Diagnostics Revenue in 2022
Figure 8. By Type - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 16. US Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 20. Germany Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 21. France Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 28. China Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 32. India Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 34. Brazil Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 37. Turkey Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Qiagen Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Illumina Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Abbott Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Hologic Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. BioMerieux Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. DAAN Gene Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Agilent Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Genomic Health Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. BD Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

※参考情報

感染症分子診断は、感染症を引き起こす病原体を特定し、その感染状態や進行具合を評価するための技術です。この診断法は、病原体の遺伝物質や抗原、抗体を検出することにより行われます。感染症の早期発見や適切な治療方針の選定に寄与することが大きな目的であり、近年の医療現場においてますます重要な役割を果たしています。

感染症分子診断の最も大きな特徴は、特異性と感度の高さです。これは、感染症の原因となる病原体を迅速かつ正確に特定できることを意味します。従来の診断法では、培養や顕微鏡検査等が行われてきましたが、これらの方法は時間がかかり、また感度や特異性も限界があります。その点、分子診断技術は病原体のDNAやRNAを直接検出するため、早期の診断が可能です。

分子診断に用いられる主な技術には、ポリメラーゼ連鎖反応（PCR）、逆転写PCR（RT-PCR）、リアルタイムPCR（qPCR）、次世代シーケンシング（NGS）などがあります。PCRは、特定の遺伝子配列を増幅する手法で、死細胞や低濃度の病原体でも検出可能となります。RT-PCRでは、RNAウイルスに対しても対応可能で、エボラウイルスや新型コロナウイルス（SARS-CoV-2）などの診断に広く用いられています。qPCRは、リアルタイムで増幅過程を観察できるため、定量的な解析ができる利点があります。NGSは、複数の病原体を同時に検出できるため、混合感染の診断や新たな病原体の発見に有用です。

感染症分子診断の用途は多岐にわたります。例えば、ウイルス感染の早期診断、細菌感染の特定、真菌や寄生虫の検出など、さまざまな病原体に対して利用されています。また、抗生物質耐性の評価や感染症の流行監視、疫学調査にも役立つため、感染症管理の重要なツールとなっています。加えて、患者の治療方針を決定するためのバイオマーカーとしても用いられることがあります。

最近では、感染症分子診断の技術革新が進み、より迅速で簡便な検査法が登場しています。例えば、ポイントオブケア（POC）テストは、医療機関の外でも迅速に診断を行える技術を提供しており、特に緊急時における迅速な対応が求められる場面で重要です。これにより、迅速な治療介入が可能となり、患者の予後を改善することが期待されています。

さらに、感染症分子診断はテレメディスンや遠隔医療との統合が進んでいます。多くの地域で専門的な検査施設が少ない中、分子診断による迅速な検査結果は、患者が適切な治療を受けるための重要な手段となります。特に、感染症の拡大を防ぐために迅速に対応できる体制が求められています。

このように、感染症分子診断は現代の医療において欠かせない要素となっており、技術が進化することでその用途も広がっています。感染症に対する理解が深まり、新たな治療法が開発される中で、分子診断技術が果たす役割はますます重要になるでしょう。未来の医療において、感染症分子診断は感染症の早期発見、効率的な治療、さらには感染症の予防に寄与し、より良い健康管理が実現できることを期待します。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 感染症分子診断の世界市場見通し2023年-2029年(Infectious Diseases Molecular Diagnostics Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

感染症分子診断の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp